KitGuru was recently able to sit down with Frank Azor, Chief Architect of Gaming Solutions at AMD. In a wide-ranging ...

D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment ...

OpenAI CEO Sam Altman says his company, a notable Nvidia customer, will use AMD's newly unveiled chips. According to AMD CEO Lisa Su, the processors can challenge Nvidia chips in a market she now ...

New legislation regulating stablecoins could reshape huge parts of the banking and payments system both domestically and ...

Ocular Therapeutix is making sure its corporate vision is 20/20 as it looks forward to phase 3 data on its eye disease drug candidate Axpaxli. | Ocular Therapeutix is making sure its corporate vision ...

Ocular Therapeutix’ investigational therapy, AXPAXLI™ (also known as OTX-TKI), is an axitinib hydrogel administered by intravitreal injection that has the potential to dramatically improve durability ...

Built around a beautiful 16-inch OLED screen, the latest Swift Go 16 improves on its predecessors without significant price ...

With the release of AMD’s new Ryzen 9000 series CPUs, we’re seeing more and more new motherboards with the latest X870 ...

We liked the AMD RX 9060 XT 16GB, awarding it a score of 85 in our review. Even the RTX 5060 Ti 16GB was described as ...

In the past three years, the AI market has been characterized by significant investments from major tech companies and ...